BioIncept

Manufacturing · New Jersey, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

1697 Lark Ln, Cherry Hill, New Jersey, 0...

Phone Number

(856) 429-2699

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About BioIncept

BioIncept, LLC is a clinical-stage biotechnology company specializing in regenerative medicine through the development of therapeutics and diagnostics based on the PreImplantation Factor (PIF). The company focuses on advancing novel therapies aimed at improving IVF outcomes and addressing complex conditions such as autoimmunity and neuro-regeneration. BioIncept's proprietary platform, Synthetic PreImplantation Factor (sPIF), represents a significant innovation in the field. As a wholly owned subsidiary of Prince Biotech, BioIncept is positioned to make impactful contributions to reproductive health and tissue regeneration.Explore more
BioIncept's Social MediaPopular SearchesBioincept LLCBioinceptIncep LLCSIC Code 28,283NAICS Code 32,325Show more

Is BioIncept your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to BioIncept

Compare insights from companies similar to BioIncept, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

BioIncept

<$5M
1-10
Private
$10.5M
2001
N/A
$5.8M
1-10
Private
-
2018
<$5M
11-50
Private
$7M
2016
Samuel Alworth, Co-Founder & Chief Executive Officer at AcuraStem
Samuel AlworthCo-Founder & CEO
<$5M
11-50
Private
-
-
<$5M
1-10
Private
<$5M
2014
BL
Betty LawrenceVice President, Toxicology & Regulatory
<$5M
1-10
Private
<$5M
2017
<$5M
1-10
Private
<$5M
2005
AR
Armin ReitmairVice President, Translational Research Consulting
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

BioIncept is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

BioIncept is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BioIncept.

BioIncept financials insights

Gather financial insights about BioIncept, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2013

Private Equity

$3.2M

2016

Private Equity

$7.3M

See All BioIncept's Financials Insights

BioIncept Tech Stack

A closer look at the technologies used by BioIncept

Top Manufacturing Companies

Frequently Asked Questions Regarding BioIncept

What is BioIncept's official website?
BioIncept's official website is www.bioincept.com
What is BioIncept's Revenue?
BioIncept's revenue is <$5 Million
What is BioIncept's SIC code?
BioIncept's SIC: 28,283
What is BioIncept's NAICS code?
BioIncept's NAICS: 32,325
How many employees does BioIncept have?
BioIncept has 1-10 employees
What industry does BioIncept belong to?
BioIncept is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is BioIncept competition?
BioIncept top competitors include: TregTherapeutics, Neutrolis, Targazyme, Ddnews
What technology does BioIncept use?
Some of the popular technologies that BioIncept uses are: WordPress.org, reCAPTCHA, PHP, Cloudflare Website Optimization
How do I contact BioIncept?
BioIncept contact info: Phone number: (856) 429-2699 Website: www.bioincept.com
What does BioIncept do?

BioIncept, LLC is a clinical-stage biotechnology company specializing in regenerative medicine through the development of therapeutics and diagnostics based on the PreImplantation Factor (PIF). The company focuses on advancing novel therapies aimed at improving IVF outcomes and addressing complex conditions such as autoimmunity and neuro-regenerati... on. BioIncept's proprietary platform, Synthetic PreImplantation Factor (sPIF), represents a significant innovation in the field. As a wholly owned subsidiary of Prince Biotech, BioIncept is positioned to make impactful contributions to reproductive health and tissue regeneration.Read More

What are BioIncept social media links?
BioIncept Linkedin page BioIncept Facebook page
Is BioIncept a public company?
BioIncept is private company therefore does not currently have an official ticker symbol
See more information about BioIncept

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.